本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Day One Biopharmaceuticals Inc.

11.11
-0.3100-2.71%
成交量:47.98萬
成交額:528.29萬
市值:11.41億
市盈率:-7.53
高:11.46
開:11.40
低:10.79
收:11.42
52周最高:13.20
52周最低:5.64
股本:1.03億
流通股本:7,876.62萬
量比:0.40
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-1.4748
每股收益(LYR):-1.0243
淨資產收益率:-30.16%
總資產收益率:-18.57%
市淨率:2.53
市盈率(LYR):-10.85

資料載入中...

公司資料

公司名字:
Day One Biopharmaceuticals Inc.
交易所:
NASDAQ
成立時間:
2018
員工人數:
184
公司地址:
1800 Sierra Point Parkway,Suite 200,Brisbane,California,United States
郵編:
94005
電話:
傳真:
- -
簡介:
Day One Biopharmaceuticals, Inc.於2018年11月在特拉華州註冊成立為一家有限責任公司。作為一家商業化階段的生物製藥公司,該公司專註於開發針對兒童和成人疾病的首創或同類最佳藥物。Day One採用搜索與開發戰略來識別、收購和推進藥物項目,其首個商業化產品是托沃拉非尼(tovorafenib)——一種口服、可穿透血腦屏障、高選擇性的II型RAF激酶抑製劑。

董事

名稱
職位
Jeremy Bender
Chief Executive Officer, President and Director
Julie Grant
Chair of the Board, Director and Co-Founder
Natalie Holles
Lead Independent Director
Dan Becker
Director
John Josey
Director
Michael Gladstone
Director
Saira Ramasastry
Director

股東

名稱
職位
Jeremy Bender
Chief Executive Officer, President and Director
Charles York II
Chief Operating Officer, Chief Financial Officer and Secretary
Julie Grant
Chair of the Board, Director and Co-Founder
Samuel Blackman
Chief Medical Officer and Co-Founder